Acquired angioedema: an unusual presentation of haematological malignancy

BMJ Case Rep. 2022 Sep 19;15(9):e249093. doi: 10.1136/bcr-2022-249093.

Abstract

A previously healthy man in his 60s being worked up for splenomegaly presented to the emergency department with recurrent episodes of angioedema. Each episode was attributed to a precipitating cause, and consequently, the predisposing C1 esterase inhibitor (C1-INH) deficiency remained undiagnosed until the third presentation. The aetiology of acquired C1-INH deficiency would be primarily obscure and require further investigations to identify. A clonal B cell population was finally isolated by flow cytometry after multiple repeat marrow samples, and a diagnosis of splenic marginal zone lymphoma was subsequently reached. Response to single-agent rituximab was observed with resolution of splenomegaly, disappearance of the antibody and restoration of C1-INH levels.

Keywords: Haematology (drugs and medicines); Haematology (incl blood transfusion); Immunology.

Publication types

  • Case Reports

MeSH terms

  • Angioedema* / diagnosis
  • Angioedema* / drug therapy
  • Angioedema* / etiology
  • Complement C1 Inhibitor Protein
  • Hematologic Neoplasms* / complications
  • Humans
  • Male
  • Rituximab / therapeutic use
  • Splenomegaly / complications

Substances

  • Complement C1 Inhibitor Protein
  • Rituximab

Supplementary concepts

  • Acquired angioedema